Browse By: Country ι Category ι Latest Reports ι Tag

Addiction - Pipeline Review, H2 2012

Pages » 362
Published By » Global Markets Direct
Price » $2000
In stock
View Report Details
Description

Global Markets Directs, 'Addiction Pipeline Review, H2 2012', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Addiction, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Addiction.  Addiction Pipeline Review, Half Year is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put togethe... Click here for more details


Sales Force Effectiveness in Pharmaceuticals - Cost Pressures Increase Pharmaceutical Companies Adoption of New Sales Models and Technologies
GBI Research’s report, “Sales Force  Effectiveness in Pharmaceuticals - Cost Pressures Increases Pharmaceutical Companies\' Adoption of New Sales Models and Technologies”, provides in-depth analysis of trends, issues and challenges in this industry. The report analyzes t
Published Date: Oct 2010
Price: $3500
Contract Manufacturing Organizations (CMO) in Eastern Europe - Inconsistent Demand and Competition from Asia Raises Concerns
GBI Research, the leading business intelligence provider, has released its latest report, “Contract Manufacturing Organizations (CMO) in Eastern Europe - Inconsistent Demand and Competition from Asia Raises Concerns” that provides key data, information and analysis of the major tre
Published Date: Oct 2010
Price: $3500
Pharmaceutical Analytical Services Outsourcing in India: Cost Savings, Product Quality and Shorter Delivery Times are Key Drivers
GBI Research’s medical devices report, “Pharmaceutical Analytical Services Outsourcing in India: Cost Savings, Product Quality and Shorter Delivery Times are Key Drivers” provides key data, information and analysis on the pharmaceutical analytical services outsourcing in in
Published Date: Nov 2010
Price: $3500
Patent Strategies - Effective Strategies for Extension of Product Lifecycles and Combating Aggressive Generics Markets
GBI Research’s new report, “Patent Strategies - Effective Strategies for Extension of Product Lifecycles and Combating Aggressive Generics Markets”, provides in-depth analysis of various patent protection strategies adopted by pharmaceutical companies for maximizing revenues re
Published Date: Dec 2010
Price: $3500
Antihypertensives Market to 2016 - Generic Erosion Following Patent Expiry of Major ARBs to Impact the Market
GBI Research, a leading business intelligence provider, has released its latest research, “Antihypertensives Market to 2016 - Generic Erosion Following Patent Expiry of Major ARBs to Impact the Market”. The report provides in-depth analysis of the unmet needs, drivers and barriers
Published Date: Dec 2010
Price: $3500
Emerging Markets for Clinical Trials in India - Favorable Regulatory Environment and Cost Effectiveness Will Accelerate the Number of Clinical Trials
GBI Researchs new report, Emerging Markets for Clinical Trials in India - Favorable Regulatory Environment and Cost Effectiveness Will Accelerate the Number of Clinical Trials, provides in-depth analysis of trends, issues and challenges in this industry. The report analyzes the effective strategie
Published Date: Jan 2011
Price: $3500
Emerging Market for Clinical Trials in China - Communication Problems and Unresolved Intellectual Property Issues Restrict Growth
GBI Research has released its pharmaceutical report, Emerging Market for Clinical Trials in China - Communication Problems and Unresolved Intellectual Property Issues Restrict Growth that provides key data, information and analysis of the major trends and issues affecting the clinical trial market
Published Date: Apr 2011
Price: $3500
Sleep Disorders Market to 2017 - Generic Substitution Coupled With a Weak Pipeline Will Negatively Impact the Market
GBI Research, the leading business intelligence provider, has released its latest research Sleep Disorders Market to 2017- Generics Substitution Coupled with a Weak Pipeline Will Negatively Impact the Market, which provides insights into sleep disorders therapeutics sales and price forecasts u
Published Date: Apr 2011
Price: $3500
Clinical Trial Recruitment Strategies in Oncology - Online Recruitment Methods and Use of IT - enabled Patient Management Systems will Reduce Recruitment Time and Cost
GBI Research has released its research, Clinical Trial Recruitment Strategies in Oncology - Online Recruitment Methods and Use of IT - enabled Patient Management Systems will Reduce Recruitment Time and Cost, which provides insights into recruitment strategies, challenges and solutions for on-
Published Date: May 2011
Price: $3500
ENT Disorders Market to 2016 - Increasing Resistance to Anti-Bacterials to Drive Development of Novel Therapies for ENT Disorders
GBI Researchs pharmaceutical report, ENT Disorders Market to 2016 - Increasing Resistance to Anti-Bacterials to Drive Development of Novel Therapies for ENT Disorders provides in-depth analysis of unmet needs, drivers and barriers that impact the global ENT disorders market. The report ana
Published Date: Apr 2011
Price: $3500

 


 

Related News

Germany Decides Not to Rely on Google to Test Autonomous Cars
The government in Germany has expressed its desire to convert a portion of the A9 Autobahn in Bavaria into what could be a testing field for advanced and innovative car technologies. According to the transport minister of Germany, this project will ensure that the country maintains its ‘digital sovereignty’.  The project is called Digitales Testfeld Autobahn and the track will most probably be launched anytime this year. The plan is to equip all the roads on the track with pr
Date: Jan 27

Auto Industry Boosts Profit for Texas Instruments
The last quarter of 2014 went exceptionally well for Texas Instruments Inc. The company closed with high revenue figures in the fourth quarter of 2014 on Monday and is expecting similar returns for the ongoing quarter as well. This steady increase in its revenue generation can be attributed to the growing demand for chips in the auto industry. The company revealed its revenue figures for the last quarter on Monday that shows a turnover of $3.27 billion. Its revenue figures have risen by 8% compa
Date: Jan 27

Apple Joins Hand with Distribution Giant Brightstar to Boost Sales in India
The maker of iPad and iPhones, Apple, has decided to collaborate with global retail giant Brightstar to boost sales for its devices in India. Apple has set an ambitious target for itself to capitalize on market opportunities in India. The electronic major is looking forward to increase sales from 1 million units that it achieved in the fiscal year ending of 2014, to 7 million units by the end of 2018.  Brightstar, the US-headquartered company is controlled by Softbank, the Japanese telec
Date: Jan 27

Brazil’s Oi to Pocket $6.7 billion Gain from PT Portugal Sale
Oi SA, the leading telecommunications company in Brazil is eyeing to book a net profit of $6.7 billion from the sale of its operating unit PT Portugal to Altice SA. According to sources, the proceeds from the sale will be used by the company to clear off its existing debts. Oi is looking forward to merge with PT Portugal’s parent company, Portugal Telecom SGPS SA. After weeks of discussion, the shareholders of Portugal Telecom finally approved the sale of its operating unit to the Luxembou
Date: Jan 27

Utah Placed Second in Toxic Chemical Releases: EPA
Utah has one of the biggest open-pit copper mines in the world. It deals with a particularly large volume of lead compounds. A recent annual record by the EPA states that Utah ranks at second place out of fifty six states and territories across the country for total toxic releases every square mile. Alaska was ranked first. In 2013, the toxic release inventory by EPA stated that Utah held nearly 12.7% of the total of such releases across the nation, having the majority of which comes from the
Date: Jan 27

US and Brazil to drive growth of bio-based materials market
Driven by growth in Brazil and the U.S., the capacity to manufacture bio-based chemicals and materials from advancing technologies, worldwide, will rise to around 7.4 million metric tons in 2018, which is more than three times from 2008 levels, as stated by Lux Research.   According to Mr. Andrew Soare, senior analyst of Lux Research, high growth is expected in North America, having 17 bio-based chemicals and materials facilities set to come online, many led by developing technology such
Date: Jan 27

Online Car Purchase Portal to be Started by AutoNation
According to Mike Jackson, the CEO of AutoNation Inc., the company will soon be applying its AutoNation Express principle to online car purchasing to Florida during the next quarter. This business expansion has taken place after the launch of AutoNation Express in December the year earlier in South of Florida.  Prior to that launch, AutoNation had altered the name from the SmartChoice Express moniker that was used by it AutoNation described this approach as its digital storefront, which
Date: Jan 23

Ford Establishes a Research and Innovation Unit in Palo Alto
The Ford Motor Company will soon be establishing an expanded Research and Innovation Center in Palo Alto. The company has plans of employing 125 people in the new building and its focus will essentially be on future technology in the areas of human-machine interface, autonomous driving, big data, car connectivity, and smart mobility. Few of the center’s employees are expected to come from Ford’s headquarters in Michigan, however, a major part of the team will be new recruits who will
Date: Jan 23

Shareholders at Portugal Telecom Holders Approve Deal with Altice
Shareholders at Portugal Telecom SGPS SA sanctioned sale of Luxembourg-based Altice SA at a price of US$8.6 billion. This finally spells a definition for the deal that was in process for a long time. The acquisition will make Altice an important competitor in Portugal, to stand next in line with NOS and Vodafone Group PLC.  At present Altice also has operations in Israel and Belgium. Patrick Drahi, the owner is firm on his stand that he intends to expand the company’s markets in th
Date: Jan 23

Vodafone India’s Managing Director Marten Pieters to Retire in April 2015
Vodafone Managing Director, India, Pieters will be retiring from his position on April 1, 2015. During his reign he took the government at every turn right from regulatory issues, tax, or auction of spectrum. He has been the longest running managing director in the history of Indian telecom industry from February 2009. The current chief operating officer, Sunil Sood will take over from Pieters to head the company. Pieters was fondly nicknamed “Crusader” Pieters was the unflinching
Date: Jan 23

Upcoming Reports

Acute Myeloid Leukemia (AML) Therapeutics Market - Global Industry Size, Market Share, Trends, Analysis And Forecasts, 2012 - 2018
Acute myeloid leukemia grows at a fast pace and is found in the blood and bone marrow. The leukemia therapeutics market is divided into four segments namely acute lymphocytic leukemia, acute myeloid leukemia, chronic lymphocytic leukemia and chronic myeloid leukemia. In the disease process, imma
Published By: Transparency Market Research
Price: $4795
Antibiotic Market - Global Industry Size, Share, Trends, Analysis And Forecast, 2012 - 2018
An antibiotic is a compound or a substance that fights bacterial infections and kills or slow down their growth. The antibiotic market is witnessing high growth due new product innovations and higher investment in R & D activity. Moreover, the other regulatory concerns to control the antibioti
Published By: Transparency Market Research
Price: $4795
Next Generation Sequencers Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019
Next generation sequencers are used inthe sequencing technologies which massively parallelize the DNA sequencing process rather than being limited to single or few fragments of DNA. The next generation sequencing (NGS) technology enables rapid sequencing and produce thousands and millions of seque
Published By: Transparency Market Research
Price: $4795
Rheumatoid Arthritis Pharmacotherapeutics Market - Global Industry Size, Market Share, Trends, Analysis And Forecast, 2012 - 2018
Treatment options for rheumatoid arthritis (RA) are expanding as a result of increasing research activities and more explicit understanding of the pathophysiology of diseases. For the treatment of RA, novel selective inhibitors such as cyclooxygenase-2 (COX-2) are used along with the non-steroidal
Published By: Transparency Market Research
Price: $4795
Prenatal Diagnostics Market - Global Industry Size, Market Share, Trends, Analysis And Forecast, 2012 - 2018
Prenatal diagnostics is a procedure for testing of diseases before the birth of a child, to determine certain inheritable disorders such as chromosome abnormalities, Down’s syndrome, genetic diseases, neural tube defects, and other conditions. It can be conducted by various procedures of scr
Published By: Transparency Market Research
Price: $4795
Pediatric Vaccines Market - Global Industry Analysis, Market Size, Market Share And Forecasts, 2012 - 2018
The global pediatric vaccine market is forecasted to reach $24.3 billion by the year 2017 at a compounded annual growth rate of 11.5 % during 2011-2017. This growth in revenues is expected to be driven by the introduction of new molecules that are currently in regulatory filing stage and those i
Published By: Transparency Market Research
Price: $4795
Dermatological Diagnostics And Therapeutics Market - Global Industry Analysis, Market Size, Market Share And Forecasts, 2012 - 2018
The Dermatological diagnostics and therapeutics market is expected to grow steadily during the forecast period driven by increase in psoriasis market that is expected to boost competition among the existing products with more emerging therapies. Acne is the largest market segment of the dermatolog
Published By: Transparency Market Research
Price: $4795
Hepatitis C Market - Global Industry Size, Share, Trends, Analysis And Forecasts 2012 - 2018
The world market for HCV drugs represents an area of potential opportunities in developed as well as developing countries. Because of the technological advancements and effectiveness, many big market players are focusing on development of innovative drugs for HCV. Major companies are forming coali
Published By: Transparency Market Research
Price: $4795
EPharmacies Market - Global Industry Size, Market Share, Trends, Analysis, And Forecasts 2012 - 2018
The global market for ePharmacies is projected to reach USD 51.75 billion by the end of 2017 owing to the increasing number of tech-savvy people and rising demand for prescription drugs. The ePharmacies meeting the regulatory standards set by the government and following ethical business practices
Published By: Transparency Market Research
Price: $4795
Congestive Heart Failure Treatment Devices Market - Global Industry Size, Share, Trends, Analysis And Forecasts 2012 - 2018
The global market for congestive heart failure treatment devices is expected to reach $5.9 billion by the year 2016 at the compounded annual growth rate of 11.7% during the forecasted period. This growth is mainly attributed by the rising incidences of heart failures across the world. American mar
Published By: Transparency Market Research
Price: $4795